title: Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
authors.affiliation: Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires y Fundación Dr Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina.
authors.forename: E R
authors.initials: ER
authors.lastname: Soriano
authors.forename: C
authors.initials: C
authors.lastname: Galarza-Maldonado
authors.forename: M H
authors.initials: MH
authors.lastname: Cardiel
authors.forename: B A
authors.initials: BA
authors.lastname: Pons-Estel
authors.forename: L
authors.initials: L
authors.lastname: Massardo
authors.forename: C V
authors.initials: CV
authors.lastname: Caballero-Uribe
authors.forename: A F
authors.initials: AF
authors.lastname: Achurra-Castillo
authors.forename: L A
authors.initials: LA
authors.lastname: Barile-Fabris
authors.forename: J
authors.initials: J
authors.lastname: Chávez-Corrales
authors.forename: J F
authors.initials: JF
authors.lastname: Díaz-Coto
authors.forename: M H
authors.initials: MH
authors.lastname: Esteva-Spinetti
authors.forename: M
authors.initials: M
authors.lastname: Guibert-Toledano
authors.forename: F Irazoque
authors.initials: FI
authors.lastname: Palazuelos
authors.forename: M W
authors.initials: MW
authors.lastname: Keiserman
authors.forename: A V
authors.initials: AV
authors.lastname: Lomonte
authors.forename: L M H
authors.initials: LM
authors.lastname: Mota
authors.forename: C
authors.initials: C
authors.lastname: Pineda Villaseñor
authors.forename: G S
authors.initials: GS
authors.lastname: Alarcón
mesh_terms: D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000075202:Contraindications; D004334:Drug Administration Schedule; D006801:Humans; D007843:Latin America; D018579:Patient Selection; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab